Skip to main content
SpineGuard logo

SpineGuard — Investor Relations & Filings

Ticker · ALSGD ISIN · FR0011464452 LEI · 969500Z4BRXQX6CSL565 PA Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2021-03-26 Legal Proceedings Report
Country FR France
Listing PA ALSGD

About SpineGuard

https://www.spineguard.com/

SpineGuard is a medical technology company that develops and markets the proprietary Dynamic Surgical Guidance (DSG) technology. DSG is a radiation-free, real-time sensing platform designed to make spine surgery safer. The technology is embedded in the company's PediGuard family of smart drilling instruments, which assist surgeons in the accurate placement of skeletal implants, particularly pedicle screws. By differentiating tissue types at the instrument's tip, the devices provide audible and visual feedback to help anticipate potential breaches of the vertebral wall, thereby enhancing procedural safety and accuracy. SpineGuard's primary goal is to establish DSG as a standard of care for securing and streamlining skeletal implant placement.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Legal Proceedings Report Classification · 99% confidence The document is an official announcement from SpineGuard dated March 26, 2021. The primary subject is the company's exit from the 'procédure de sauvegarde' (safeguard procedure) following a court decision, detailing the restructuring of its liabilities (including US Chapter 11 alignment). This type of announcement, detailing significant legal/financial restructuring outcomes and future outlook, often falls under general regulatory announcements or specific financial updates. However, the core event is a major legal/financial proceeding resolution. It is not a full Annual Report (10-K), an Earnings Release (ER), or a standard Interim Report (IR). It is an announcement concerning a major financial/legal event. Since there is no specific code for 'Restructuring Announcement' or 'Legal Proceeding Resolution,' we must evaluate the closest fits. It details the resolution of a legal/financial proceeding (safeguard/Chapter 11). This strongly relates to 'Legal Proceedings Report' (LTR) or a general 'Regulatory Filing' (RNS). Given the focus on the court-validated plan and debt settlement, LTR is a strong candidate, but LTR is defined as 'Updates on significant lawsuits, regulatory actions, or legal matters.' The exit from safeguard is a resolution of a legal/financial matter. Alternatively, since it is a formal announcement of a significant corporate event not covered by other specific codes (like DIV, CAP, MANG), it could be RNS. However, the content is highly specific to the resolution of a legal/financial protection procedure. Since the document also announces a future webinar tied to the upcoming 2020 Annual Results and Q1 2021 revenue, it has elements of an announcement about future reporting (RPA). Given the primary, immediate news is the successful conclusion of the safeguard procedure, which is a major legal/financial event, LTR is the most descriptive category for the main body of the text. If LTR is too narrow (focusing only on lawsuits), RNS is the fallback. Considering the detailed breakdown of debt restructuring resulting from the legal process, LTR is chosen over the general RNS.
2021-03-26 French
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release dated February 15, 2021, announcing that SpineGuard has obtained FDA clearance (510K #201454) for the commercial release of its 'DSG Connect' platform in the USA. This type of announcement, detailing a significant regulatory milestone (FDA clearance) and its implications for market access, is a general corporate update. It is not a formal financial report (like 10-K or IR), a management change (MANG), or a director's dealing (DIRS). Since it is a specific announcement about a regulatory/product development event that doesn't fit perfectly into the core financial reporting categories, it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for significant, non-standard corporate news releases.
2021-02-15 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated February 15, 2021, announcing that the company SpineGuard has obtained FDA 510K clearance (#201454) for marketing its 'DSG Connect' platform in the United States. This is a specific, material event announcement concerning regulatory approval for a medical device. It is not a comprehensive annual report (10-K), an interim report (IR), an earnings release (ER), or a standard regulatory filing (RNS). Since it details a significant business development, specifically regulatory clearance impacting market access, it best fits under a general announcement category. Given the provided definitions, it is not a perfect fit for any specific financial filing code, but it is a significant corporate announcement. It is not a Director's Dealing (DIRS), Capital Change (CAP), or Dividend (DIV). It is most closely related to a general corporate update or regulatory event. Since there is no specific code for 'Regulatory Approval Announcement', and it is not a standard SEC filing, the most appropriate fallback category for a significant, non-standard regulatory/business update is 'Regulatory Filings' (RNS), or potentially 'Capital/Financing Update' (CAP) if the approval is viewed as enabling future financing, but RNS is a better general fit for non-financial regulatory news.
2021-02-15 French
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release dated February 2, 2021, announcing a collaboration between SpineGuard and the European project FAROS regarding surgical robotics. It details the project scope, participants, and the role of SpineGuard's DSG technology. This type of announcement, focusing on strategic partnerships, research, and technological development, does not fit neatly into standard periodic financial reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, DIRS). It is a general corporate update or news release. Since it is not a formal regulatory filing like a 10-K or a specific report like an AR or IR, and it is not an announcement of a report publication (RPA), the most appropriate general category for significant, non-standard corporate news is Regulatory Filings (RNS), which serves as a broad category for miscellaneous announcements.
2021-02-02 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated February 2, 2021, announcing that SpineGuard is collaborating on the European project FAROS (Functional Accurate RObotic Surgery). It details the project's goals, funding (Horizon 2020), participating universities, and SpineGuard's specific contribution using its DSG technology. This type of announcement, detailing strategic partnerships, research collaborations, or significant operational news that is not a mandatory periodic financial filing (like 10-K or IR) or a specific corporate action (like dividend or management change), typically falls under general regulatory announcements or investor relations news. Since it is a specific announcement of a strategic development rather than a general regulatory filing fallback (RNS), and it doesn't fit any other specific category (like ER, CAP, MANG, etc.), it is best classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were a slide deck, but given the format, RNS is the most appropriate general category for non-standard, material news releases that aren't explicitly covered elsewhere. However, given the context of providing detailed information about a strategic project, it is a material announcement. Since there is no specific category for 'Strategic Partnership Announcement' or 'Research Collaboration,' and it is not a financial report, RNS (Regulatory Filings / Miscellaneous Announcements) is the best fit among the provided options for a non-standard press release.
2021-02-02 French
Inside Information / Information on annual revenues
Earnings Release Classification · 95% confidence The document reports the company's 'full-year 2020 revenue' and provides detailed quarterly and full-year financial figures (€ thousands table) comparing 2020 to 2019. It also includes commentary from the CEO regarding business performance, the impact of COVID-19, and updates on legal proceedings (safeguard plan/Chapter 11). This content structure—reporting specific period financial results with management commentary—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since the document explicitly states 'reported today its full-year 2020 revenue' and provides the full annual breakdown, it functions as the primary announcement of the annual financial performance highlights. Although it contains some financial detail, it is not the comprehensive 10-K. It is best classified as an Earnings Release (ER), which typically covers the key results for the period being reported (in this case, the full year). It is not a transcript (CT), a formal audit report (AR), or a management discussion and analysis (MDA) which is usually a separate, more narrative section following the initial release. FY 2020
2021-01-27 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.